Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

3.35
Delayed Data
As of Apr 28
 +0.02 / +0.60%
Today’s Change
2.35
Today|||52-Week Range
6.36
+21.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$106.9M

Company Description

Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products. It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Contact Information

Cardiome Pharma Corp.
1441 Creekside Drive
Vancouver British Columbia V6J 4S7
P:(604) 677-6905
Investor Relations:
16046776905311

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

William L. HunterPresident, Chief Executive Officer & Director
Sheila M. GrantChief Operating Officer
Jennifer ArchibaldChief Financial Officer
Steen Juul-MöllerMedical Director-Europe
Jürgen PolifkaGeneral Manager-European Sales & Marketing